Yahoo
Tokyo - Delayed Quote JPY

M3, Inc. (2413.T)

1,840.50 -4.00 (-0.22%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 2413.T
  • Previous Close 1,844.50
  • Open 1,858.50
  • Bid 1,840.00 x --
  • Ask 1,847.50 x --
  • Day's Range 1,840.50 - 1,887.50
  • 52 Week Range 1,297.00 - 2,746.00
  • Volume 2,182,400
  • Avg. Volume 4,141,833
  • Market Cap (intraday) 1.25T
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 26.81
  • EPS (TTM) 68.66
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 22.00 (1.20%)
  • Ex-Dividend Date Mar 30, 2026
  • 1y Target Est 1,973.33

M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Yakucari, a job search website for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

corporate.m3.com

17,010

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2413.T
11.74%
Nikkei 225 (^N225)
25.73%

1-Year Return

2413.T
12.81%
Nikkei 225 (^N225)
23.31%

3-Year Return

2413.T
16.39%
Nikkei 225 (^N225)
106.18%

5-Year Return

2413.T
71.31%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 90.11B
Earnings 9.07B
Profit Margin 10.07%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
20B
40B
60B
80B
10.0%
12.0%
14.0%
16.0%
18.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

1,600.00 Low
1,973.33 Average
1,840.50 Current
2,850.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.04%

  • Return on Assets (ttm)

    7.02%

  • Return on Equity (ttm)

    11.98%

  • Revenue (ttm)

    355.27B

  • Net Income Avi to Common (ttm)

    46.33B

  • Diluted EPS (ttm)

    68.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    162.17B

  • Total Debt/Equity (mrq)

    8.47%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: